DASATINIB | DASATINIB | ATC L01XE06
ANTINEOPLASTIC PROTEIN KINASE INHIBITORS TREATMENT OF CHRONIC MYELOID LEUKEMIA (CML) IN CHRONIC PHASE | ORAL | VD 2505 LITER PPB 96 PERCENT Cl 433 LITER / HOUR (EQN) HT 4 HOUR SOLUBILITY INSOLUBLE IN WATER | BCR-ABL ABL1 SRC FAMILY (SRC, LCK, YES, FYN) C-KIT EPHA2 PDGFR BETA PDB 2Y6O (CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH DASATINIB.) LIGAND CODE = 1N1 (link to the list of PDB complexes) Download experimental 3D coordinates of 1N1 with added hydrogens | TYROSINE-PROTEIN KINASE ABL INHIBITOR CHEMBL1862 TYROSINE-PROTEIN KINASE ABL P00519 TYROSINE-PROTEIN KINASE ABL1 HOMO SAPIENS ENZYME KINASE PROTEIN KINASE TK ABL | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |